Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             91 results found
no title author magazine year volume issue page(s) type
1 Accuracy of NVP score as a predictor of gastroesophageal varices in primary biliary cholangitis Miranda Maciel, RA

27 S3 p.
article
2 Acute liver failure and experience with therapy using the molecular absorbent recirculation system (MARS) García-Juárez, FI

27 S3 p.
article
3 Acute-on-chronic liver failure or Alcoholic Hepatitis? In patients with chronic alcoholic liver disease Chicas López, R

27 S3 p.
article
4 An unusual complication after variceal band ligation: complete esophageal obstruction, a case report and review of the literature Figueroa-Palafox, M

27 S3 p.
article
5 Assessment of cellular proliferation, death and senescence in a model of steatosis in vitro Campos-Espinosa, A

27 S3 p.
article
6 Association between hypothyroidism and non-alcoholic fatty liver disease Zuarth-Vázquez, J

27 S3 p.
article
7 Autoimmune hemolytic anemia as a paraneoplastic syndrome in hepatocarcinoma, case report Alegría-Ovando, MC

27 S3 p.
article
8 Autoimmune hepatitis (HAI) is likely induced by Epstein Barr Virus (EBV) infection Medina Avalos, EJ

27 S3 p.
article
9 Autoimmune hepatitis with superimposition of primary sclerosing cholangitis on non-specific chronic ulcerative colitis Sandoval Mendoza, JS

27 S3 p.
article
10 Causes of decompensation of liver cirrhosis and predictors of in-hospital mortality in patients admitted to the gastroenterology service of the Regional Hospital Lic. Adolfo López Mateos in the years 2017 - 2018 Velasco Gutiérrez, M

27 S3 p.
article
11 Changes in early visual perception in patients with minimal hepatic encephalopathy Montemira-Orozco, D

27 S3 p.
article
12 Changes in physical activity and its impact on MAFLD during the COVID-19 pandemic García-Carvajal, MJJ

27 S3 p.
article
13 Characteristics of patients with acute over chronic liver failure (ACLF) and risk of mortality due to amount of alcohol, MELD and MELD NA Medina Avalos, EJ

27 S3 p.
article
14 Characterization of acute kidney injury among Mexican patients with cirrhosis Carmona-Castillo, MY

27 S3 p.
article
15 Characterization of primary biliary cholangitis in a Mexican population in patients from the Hospital General de México Domínguez Cardoso, PF

27 S3 p.
article
16 Comparison of the meld-la model as a predictor of early mortality in Mexican patients with chronic decompensated liver disease Enríquez-Constantino, A

27 S3 p.
article
17 Complete genome sequence of Hepatitis C Virus isolated in Mexico López-Riojas, K

27 S3 p.
article
18 Congenital hepatic fibrosis as a rare cause of non-cirrhotic portal hypertension Santana Montes, MO

27 S3 p.
article
19 Detection of Hepatitis C and risk factors in the general population of the Centro Médico Nacional La Raza Salazar Hinojosa, GD

27 S3 p.
article
20 Dietary supplementation with methyl donors improves physiopathological conditions of NAFLD in a murine model Vazquez Esqueda, A

27 S3 p.
article
21 Diethylnitrosamine and 2-acetylaminofluorene chronic administration leads to biochemical and histologic changes related to hepatocellular carcinoma in Wistar rats Sánchez-Meza, J

27 S3 p.
article
22 Differences in mortality and prognostic scales according to ACLF grade Nava-Arceo, R

27 S3 p.
article
23 EDITORIAL BOARD
27 S3 p.
article
24 Effect of zinc supplementation in patients with cirrhosis and dysgeusia Juárez-Hernández, E.

27 S3 p.
article
25 Effects of in vitro lipid overload on LX-2 hepatic stellate cells Campos-Espinosa, A

27 S3 p.
article
26 Efficacy and safety of treatment with terlipressin infusion vs. bolus in gastrointestinal bleeding of variceal origin in a third-level hospital Moreno Aguilar, N

27 S3 p.
article
27 Epidemiologic profile of non-alcoholic fatty liver disease in apparently healthy blood bank donors Lira-Vera, JE

27 S3 p.
article
28 Etiology and find in portal vein thrombosis at the Hospital de Especialidades del Centro Médico Nacional La Raza Morales Osorio, G

27 S3 p.
article
29 Evaluation of deubiquiyinase USP15 expression during HCV replication Bazaldúa-Ramos, L

27 S3 p.
article
30 Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption Hernandez-Santillan, M

27 S3 p.
article
31 Evaluation of the early response to empirical treatment and its association with cultures in patients with spontaneous bacterial peritonitis (SBP) Carrión, ST

27 S3 p.
article
32 Evaluation of the hypolipidemic effect of cinnamon essential oil in a model of acute damage induced by triton WR-1339 De la Rosa-García, JM

27 S3 p.
article
33 Frequency of bleeding due to ulcer associated with H. Pylori (HP) in patients with liver cirrhosis at Hospital Juárez de México Mendoza Sangeado, R

27 S3 p.
article
34 Frequency of the association of metabolic syndrome in patients with liver cirrhosis hospitalized for variceal hemorrhage at Hospital Juárez de México Deaquino Reyes, T

27 S3 p.
article
35 Giant simple hepatic cyst, when and how to treat it García Espinosa, IA

27 S3 p.
article
36 Hepatic hydrothorax resistant to diuretics treated with octreotide Teutli-Carrión, S

27 S3 p.
article
37 Hepatic MIR-122-3P, MIR-140-5P and MIR-148B-5P expressions are correlated with cytokeratin-18 serum levels in MAFLD López-Sánchez, GN

27 S3 p.
article
38 Hepatitis C virus NS5A and core proteins regulate epithelial-mesenchymal transition biomarkers in hepatoma cells Heredia-Torres, TG

27 S3 p.
article
39 Hepatoprotective effect of caffeine against ischemia-reperfusion damage Garza-Guzmán, D

27 S3 p.
article
40 Identification of resistance mutations to DAA's against Hepatitis C Virus in infected subjects in Mexico López-Riojas, K

27 S3 p.
article
41 Incidence and risk factors of Chronic Viral Hepatitis type C in persons deprived of their liberty in the Social Rehabilitation Center (CERESO) of the state of Veracruz Guzmán Terrones, MT

27 S3 p.
article
42 Increase in liver fibrosis in patients with inflammatory bowel disease at the inflammatory bowel disease clinic, Centro Medico Nacional 20 de noviembre Severino-Ferreras, IE

27 S3 p.
article
43 In vitro evaluation of the antifibrogenic effect of tamsulosin during its interaction with activated stellate cells Buendía-Delgado, RJ

27 S3 p.
article
44 Jejunal lymphoma of large cell high grade B monomorphic in a patient with hepatic transplant Trujillo Lejía, AD

27 S3 p.
article
45 Left-sided portal hypertension as a complication of chronic pancreatitis in a young patient. A case report Dorantes-Nava, CL

27 S3 p.
article
46 Liquid biopsy of patients with advanced liver fibrosis reveals the association of methylation in CpGs and miRNAs expression with the degree of severity De la Rosa-Bibiano, R

27 S3 p.
article
47 Liver transplantation, experience at the general hospital of Mexico during the last four years García Juárez, FI

27 S3 p.
article
48 Management of internal hemorrhoidal bleeding refractory to endoscopic treatment in a patient with liver cirrhosis Soriano-Márquez, JP

27 S3 p.
article
49 Manifestations of SARS-COV-2 in patients with chronic liver disease Jiménez-Partida, AE

27 S3 p.
article
50 Mediterranean diet vs. regional diet in a Mexican population with MAFLD: 3-month cohort García-Carvajal, MJJ

27 S3 p.
article
51 MELD Na and MELD 3.0 have the best performance in predicting the risk of death at 28 days in patients with severe alcoholic hepatitis in the Mexican population Dorantes-Nava, CL

27 S3 p.
article
52 Metabolic-associated fatty liver disease (MAFLD) is not associated with bone mineral density (BMD) alterations in Mexican women: a cross-sectional study López-Sánchez, GN

27 S3 p.
article
53 MMP-7 is a non-invasive biomarker of chronic liver diseases Montes de Oca-Angeles, D

27 S3 p.
article
54 Moringa oleifera decreases biomarkers of oxidative stress in a murine NASH model Monraz-Méndez, A

27 S3 p.
article
55 Norepinephrine in infusion as an alternative to large volume post-paracentesis albumin in patients with cirrhosis Morales-Mairena, E

27 S3 p.
article
56 Notable intestinal dysbiosis orchestrated by Escherichia/Shigella, decreased levels of SCFTA (short chain fatty acids) and alterations in metabolic pathways characterize patients with alcohol-decompensated cirrhosis in western Mexico Baltazar-Díaz, TA

27 S3 p.
article
57 Overlay of autoimmune cholangitis and autoimmune hepatitis Cervantes Espinoza, KM

27 S3 p.
article
58 Pilot study: management with pentoxifylline in patients with chronic liver disease and COVID-19 Jiménez-Luévano, MA

27 S3 p.
article
59 Pirfenidone ameliorates MAFLD by improving insulin sensitivity and reducing epididymal fat Gutiérrez-Cuevas, J.

27 S3 p.
article
60 Pirfenidone regulates antioxidant response via NRF2 in an experimental model of hepatocellular carcinoma Monroy-Ramírez, HC

27 S3 p.
article
61 Post-infantile giant cell hepatitis, management, six-year follow-up and re-transplantation, a successful case report during the pandemic Sosa Martínez, R

27 S3 p.
article
62 Precipitating factors of kidney injury in patients with liver cirrhosis Sánchez Salinas, F

27 S3 p.
article
63 Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients Burak-Leipuner, A

27 S3 p.
article
64 Prevalence of hepatobiliary manifestations and its relationship with the time of evolution of inflammatory bowel disease in patients attended at Centro Médico Nacional 20 de noviembre Rodríguez Muñoz, LO

27 S3 p.
article
65 Prevalence of hepatobiliary manifestations in patients with inflammatory bowel disease Carrillo Rojas, JI

27 S3 p.
article
66 Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients Burak-Leipuner, A

27 S3 p.
article
67 Prevalence of liver fibrosis determined by non-invasive methods in patients with metabolic disorders at the Centro Medico Nacional 20 de noviembre Peña-Genaro, KG

27 S3 p.
article
68 Prevalence of non-alcoholic fatty liver disease in apparently healthy blood bank donors: metabolic, alcohol, and combined damage Lira-Vera, JE

27 S3 p.
article
69 Reactivation autoimmune hepatitis report of two cases Toranzo González, CJ

27 S3 p.
article
70 Risk of multiple drug interactions potentially linked to safety in patients receiving pangenotypic direct-acting antivirals for the treatment of Hepatitis C Mendez-Navarro, J

27 S3 p.
article
71 Role of tamsulosin in recovery from thioacetamide-induced subchronic liver damage in a Wistar rat model Soleil, Samson

27 S3 p.
article
72 Sarcopenia as a predictor of risk of minimal hepatic encephalopathy in patients with liver cirrhosis Gutiérrez, O Morales

27 S3 p.
article
73 Sclerosing cholangitis associated with IgG4 disease. Case Report Castro, A Torres

27 S3 p.
article
74 Screening program for hepatitis c virus in an open population at a third-level healthcare center Higuera-de la Tijera, F

27 S3 p.
article
75 Serum determination of IL-1β and IL-1RA in patients with chronic liver diseases Hernandez-Barragan, A

27 S3 p.
article
76 Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C Lemus-Peña, M

27 S3 p.
article
77 Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study Moreno-Cobos, AB

27 S3 p.
article
78 Short-term response of p300 evoked potential in patients with minimal hepatic encephalopathy treated with l-ornithine, l-aspartate Hinojosa-Segura, CI

27 S3 p.
article
79 Spontaneous elimination of the Hepatitis C virus at the CMN la Raza specialty hospital Cruz Saucedo, AY

27 S3 p.
article
80 Susceptibility to liver damage in women due to risky alcohol consumption Morales-Mairena, E

27 S3 p.
article
81 Symptomatic giant cavernous hemangioma as an indication for liver transplantation García Espinosa, IA

27 S3 p.
article
82 The administration of pirfenidone modifies the expression of JMJD2B in a murine model of NASH Rodriguez Sanabria, JS

27 S3 p.
article
83 The gut microbiota and key parameters associated with MAFLD are modified by MEXMIX Rosas-Campos, R

27 S3 p.
article
84 The Stroop test validation in the detection of minimal hepatic encephalopathy in Mexican patients with cirrhosis, preliminary results Domínguez Cardoso, PF

27 S3 p.
article
85 The usefulness of 3 different points of the liver to evaluate fibrosis by transitional elastography Morales-Mairena, E

27 S3 p.
article
86 To present a clinical case of a 52-year-old female patient with a diagnosis of pyogenic liver abscesses Ortega-García, RJ

27 S3 p.
article
87 Treatment with nucleoside and nucleotide analogues in patients with chronic hepatitis B virus infection González Rodríguez, CA

27 S3 p.
article
88 Trends of autoimmune liver diseases in the University Hospital, UANL for 26 years. A single-center experience in Mexico Munoz-Espinosa, LE

27 S3 p.
article
89 Tyrosinemia in a toddler, a case report Gómez Vidrio, GA

27 S3 p.
article
90 Use of glecaprevir and pibrentasvir as rescue therapy in patients with resistance to direct-acting antiviral agents Juarez Chavez, LS

27 S3 p.
article
91 6-Week mortality predictors in patients with acute variceal bleeding from the western national medical center of the Mexican social security institute Martín-Flores, UI

27 S3 p.
article
                             91 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands